Aradigm Corporation   Report issue

For profit Phase 1 Phase 3
Founded: Hayward CA United States (1991)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2010
NCT00889967
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Aradign Corportation

Active Ingredients

Drugs in Phase 3 Trials (1)

ciprofloxacin (cipro) (3 trials)

Drugs in Phase 1 Trials (1)

cromoglicic acid (Intal) (1 trial)

Drugs in Other Trials (1)

cefazolin (ancef) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchiectasis (Phase 3)

Fibrosis (Phase 3)

Gastroesophageal Reflux (Phase 1)

Idiopathic Pulmonary Fibrosis (Phase 1)

Pulmonary Fibrosis (Phase 1)

Respiratory Aspiration (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3